{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:16:58Z","timestamp":1790731018008,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T00:00:00Z","timestamp":1149552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oral Implants Res"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To assess the microbiological outcome of local administration of minocycline hydrochloride microspheres 1\u2003mg (Arestin\n                    <jats:sup>\u00ae<\/jats:sup>\n                    ) in cases with peri\u2010implantitis and with a follow\u2010up period of 12 months.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Material and methods:<\/jats:bold>\n                    After debridement, and local administration of chlorhexidine gel, peri\u2010implantitis cases were treated with local administration of minocycline microspheres (Arestin\n                    <jats:sup>\u00ae<\/jats:sup>\n                    ). The DNA\u2013DNA checkerboard hybridization method was used to detect bacterial presence during the first 360 days of therapy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    At Day 10, lower bacterial loads for 6\/40 individual bacteria including\n                    <jats:italic>Actinomyces gerensceriae<\/jats:italic>\n                    (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.1),\n                    <jats:italic>Actinomyces israelii<\/jats:italic>\n                    (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.01),\n                    <jats:italic>Actinomyces naeslundi<\/jats:italic>\n                    type 1 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.01) and type 2 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.03),\n                    <jats:italic>Actinomyces odontolyticus<\/jats:italic>\n                    (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.01),\n                    <jats:italic>Porphyromonas gingivalis<\/jats:italic>\n                    (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.01) and\n                    <jats:italic>Treponema socranskii<\/jats:italic>\n                    (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.01) were found. At Day 360 only the levels of\n                    <jats:italic>Actinobacillus actinomycetemcomitans<\/jats:italic>\n                    were lower than at baseline (mean difference: 1 \u00d7 10\n                    <jats:sup>5<\/jats:sup>\n                    ; SE difference: 0.34 \u00d7 10\n                    <jats:sup>5<\/jats:sup>\n                    , 95% CI: 0.2 \u00d7 10\n                    <jats:sup>5<\/jats:sup>\n                    to 1.2 \u00d7 10\n                    <jats:sup>5<\/jats:sup>\n                    ;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.03). Six implants were lost between Days 90 and 270. The microbiota was successfully controlled in 48%, and with definitive failures (implant loss and major increase in bacterial levels) in 32% of subjects.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    At study endpoint, the impact of Arestin\n                    <jats:sup>\u00ae<\/jats:sup>\n                    on\n                    <jats:italic>A. actinomycetemcomitans<\/jats:italic>\n                    was greater than the impact on other pathogens. Up to Day 180 reductions in levels of\n                    <jats:italic>Tannerella forsythia<\/jats:italic>\n                    ,\n                    <jats:italic>P. gingivalis<\/jats:italic>\n                    , and\n                    <jats:italic>Treponema denticola<\/jats:italic>\n                    were also found. Failures in treatment could not be associated with the presence of specific pathogens or by the total bacterial load at baseline. Statistical power analysis suggested that a case control study would require approximately 200 subjects.\n                  <\/jats:p>","DOI":"10.1111\/j.1600-0501.2006.01269.x","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T04:52:57Z","timestamp":1149569577000},"page":"386-393","source":"Crossref","is-referenced-by-count":101,"title":["Antimicrobial therapy using a local drug delivery system (Arestin\n                    <sup>\u00ae<\/sup>\n                    ) in the treatment of peri\u2010implantitis. I: microbiological outcomes"],"prefix":"10.1111","volume":"17","author":[{"given":"G. Rutger","family":"Persson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni E.","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J. A.","family":"Heitz\u2010Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklaus P.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2004.06.005"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2005.00720.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/154405910508400312"},{"key":"e_1_2_6_5_1","volume-title":"Statistical Methods for Rates and Proportions","author":"Fleiss J.L.","year":"1981"},{"key":"e_1_2_6_6_1","first-page":"829","article-title":"Microbiota around root\u2010form endosseous implants","volume":"17","author":"Heydenrijk K.","year":"2002","journal-title":"International Journal of Oral & Maxillofacial Implants"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0501.2002.130402.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0501.2005.01141.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.2004.00200.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051X.29.s3.13.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0501.2003.01871.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.5.1559"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2002.73.11.1292"},{"key":"e_1_2_6_14_1","first-page":"201","article-title":"Early implant failures in patients treated with Branemark system titanium dental implants","volume":"16","author":"Kronstr\u00f6m M.","year":"2001","journal-title":"International Journal of Oral & Maxillofacial Implants"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2003.74.10.1415"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2004.08.002"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.2004.00763.x"},{"key":"e_1_2_6_18_1","first-page":"317","volume-title":"Proceedings of the 1st European Workshop on Periodontology","author":"Mombelli A.","year":"1994"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0757.1998.tb00115.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0501.2001.012004287.x"},{"key":"e_1_2_6_21_1","first-page":"8","article-title":"Combined effects of Nd:YAG laser irradiation with local antibiotic application into periodontal pockets","volume":"7","author":"Noguchi T.","year":"2005","journal-title":"Journal of International Academy of Periodontology"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0501.1996.090602.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051X.2003.00375.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.12.3770-3783.2001"},{"key":"e_1_2_6_25_1","first-page":"154","article-title":"Treatment of incipient peri\u2010implantitis infections using topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement","volume":"6","author":"Renvert S.","year":"2004","journal-title":"Journal of the International Academy of Periodontology"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2004.00493.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0501.2004.01084.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051X.2003.00296.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0501.2001.012003189.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-302X.2001.160610.x"},{"key":"e_1_2_6_31_1","first-page":"32","article-title":"The clinical, microbial, and host response characteristics of the failing implant","volume":"12","author":"Salcetti J.M.","year":"1997","journal-title":"International Journal of Oral and Maxillofacial Implants"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0757.2002.280102.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1998.tb02419.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302x.2004.00168.x"},{"key":"e_1_2_6_35_1","first-page":"788","article-title":"\u201cCheckerboard\u201d DNA\u2013DNA hybridization","volume":"17","author":"Socransky S.S.","year":"1994","journal-title":"Biotechniques"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2001.72.11.1535"}],"container-title":["Clinical Oral Implants Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0501.2006.01269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0501.2006.01269.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:28:27Z","timestamp":1697437707000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0501.2006.01269.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,6]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1111\/j.1600-0501.2006.01269.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0501.2006.01269.x","archive":["Portico"],"relation":{},"ISSN":["0905-7161","1600-0501"],"issn-type":[{"value":"0905-7161","type":"print"},{"value":"1600-0501","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,6]]}}}